newsfilter
← Latest News
Business Wire·

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 1, 2023 – ImmunoGen, Inc., (NASDAQ:IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the compensation committee of the Company's Board of